RESUMO
BACKGROUND: Somatic genetic variants may be the cause of extracranial arteriovenous malformations, but few studies have explored these genetic anomalies, and no genotype-phenotype correlations have been identified. OBJECTIVES: The aim of the study was to characterize the somatic genetic landscape of extracranial arteriovenous malformations and correlate these findings with the phenotypic characteristics of these lesions. METHODS: This study included twenty-three patients with extracranial arteriovenous malformations that were confirmed clinically and treated by surgical resection, and for whom frozen tissue samples were available. Targeted next-generation sequencing analysis of tissues was performed using a gene panel that included vascular disease-related genes and tumour-related genes. RESULTS: We identified a pathogenic variant in 18 out of 23 samples (78.3%). Pathogenic variants were mainly located in MAP2K1 (n = 7) and KRAS (n = 6), and more rarely in BRAF (n = 2) and RASA1 (n = 3). KRAS variants were significantly (P < 0.005) associated with severe extended facial arteriovenous malformations, for which relapse after surgical resection is frequently observed, while MAP2K1 variants were significantly (P < 0.005) associated with less severe, limited arteriovenous malformations located on the lips. CONCLUSIONS: Our study highlights a high prevalence of pathogenic somatic variants, predominantly in MAP2K1 and KRAS, in extracranial arteriovenous malformations. In addition, our study identifies for the first time a correlation between the genotype, clinical severity and angiographic characteristics of extracranial arteriovenous malformations. The RAS/MAPK variants identified in this study are known to be associated with malignant tumours for which targeted therapies have already been developed. Thus, identification of these somatic variants could lead to new therapeutic options to improve the management of patients with extracranial arteriovenous malformations.
Assuntos
Malformações Arteriovenosas , Proteínas Proto-Oncogênicas p21(ras) , Malformações Arteriovenosas/genética , Estudos de Associação Genética , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Mutação , Proteínas Proto-Oncogênicas p21(ras)/genética , Proteína p120 Ativadora de GTPase/genéticaRESUMO
We recently highlighted a novel potential protective paracrine role of cardiac myeloid CD11b/c cells improving resistance of adult hypertrophied cardiomyocytes to oxidative stress and potentially delaying evolution towards heart failure (HF) in response to early ß-adrenergic stimulation. Here we characterized macrophages (Mφ) in hearts early infused with isoproterenol as compared to control and failing hearts and evaluated the role of upregulated CX3CL1 in cardiac remodeling. Flow cytometry, immunohistology and Mφ-depletion experiments evidenced a transient increase in Mφ number in isoproterenol-infused hearts, proportional to early concentric hypertrophy (ECH) remodeling and limiting HF. Combining transcriptomic and secretomic approaches we characterized Mφ-enriched CD45+ cells from ECH hearts as CX3CL1- and TNFα-secreting cells. In-vivo experiments, using intramyocardial injection in ECH hearts of either Cx3cl1 or Cx3cr1 siRNA, or Cx3cr1-/- knockout mice, identified the CX3CL1/CX3CR1 axis as a protective pathway delaying transition to HF. In-vitro results showed that CX3CL1 not only enhanced ECH Mφ proliferation and expansion but also supported adult cardiomyocyte hypertrophy via a synergistic action with TNFα. Our data underscore the in-vivo transient protective role of the CX3CL1/CX3CR1 axis in ECH remodeling and suggest the participation of CX3CL1-secreting Mφ and their crosstalk with CX3CR1-expressing cardiomyocytes to delay HF.
Assuntos
Agonistas Adrenérgicos beta/efeitos adversos , Receptor 1 de Quimiocina CX3C/metabolismo , Quimiocina CX3CL1/metabolismo , Insuficiência Cardíaca/induzido quimicamente , Insuficiência Cardíaca/metabolismo , Isoproterenol/efeitos adversos , Macrófagos/metabolismo , Miócitos Cardíacos/metabolismo , Transdução de Sinais/genética , Animais , Receptor 1 de Quimiocina CX3C/genética , Comunicação Celular/genética , Proliferação de Células/genética , Células Cultivadas , Quimiocina CX3CL1/genética , Modelos Animais de Doenças , Insuficiência Cardíaca/genética , Hipertrofia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Miócitos Cardíacos/patologia , RNA Interferente Pequeno/administração & dosagem , RNA Interferente Pequeno/genética , Fator de Necrose Tumoral alfa/metabolismo , Remodelação Ventricular/genéticaRESUMO
The molecular mechanisms of salt sensitivity and the contribution of the kidney to salt-induced hypertension in Sabra rats are imperfectly defined. We investigated the expression of the nitric oxide (NO) system (endothelial, inducible, and neural NO synthases) and renin-angiotensin system (renin, angiotensinogen, and angiotensin II type 1A receptor) gene components in the kidneys of SBN/y (salt-resistant) and SBH/y (salt-sensitive) Sabra rat substrains, with and without deoxycorticosterone acetate (DOCA)-salt treatment. We also looked for immunocytochemical evidence of angiotensin II, the effector peptide of the renin-angiotensin system. Inducible and neural NO synthase gene expression values were lower in SBH/y than in SBN/y before and after DOCA-salt treatment. The gene expression level of endothelial NO synthase was not different in SBH/y and SBN/y, either with or without DOCA salt. Renin gene expression was significantly higher in kidneys of SBN/y than in kidneys of SBH/y rats, whereas angiotensinogen gene expression was significantly lower in SBN/y. After DOCA-salt treatment, renin gene expression was strongly suppressed in both strains but more so in SBH/y. Angiotensinogen gene expression, on the other hand, was increased by DOCA salt in SBN/y rats so that the two strains were no longer different. Angiotensin II immunoreactivity was significantly higher in SBN/y than in SBH/y; however, after DOCA salt, immunoreactivity in both strains was no longer detectable. Angiotensin II type 1A receptor gene expression was not different between the two strains, either before or after DOCA-salt administration. We conclude that DOCA salt induced a decrease in the activity of the renin-angiotensin system but did not change NO synthase gene expression in SBH/y and SBN/y. Inducible and neural NO synthase gene expression values were less in SBH/y than in SBN/y, independent of DOCA-salt administration. Thus, the NO system could explain, at least in part, the salt resistance of SBN/y.
Assuntos
Expressão Gênica , Óxido Nítrico Sintase/genética , Ratos Mutantes/genética , Sistema Renina-Angiotensina/genética , Cloreto de Sódio/farmacologia , Angiotensina II/metabolismo , Animais , Desoxicorticosterona/farmacologia , Resistência a Medicamentos/genética , Endotélio Vascular/enzimologia , Indução Enzimática , Hipertensão/induzido quimicamente , Hipertensão/genética , Hipertensão/metabolismo , Imuno-Histoquímica , Rim/metabolismo , Masculino , Sistema Nervoso/enzimologia , Ratos , Valores de ReferênciaRESUMO
BACKGROUND: The roles of nitric oxide synthases (NOS) in kidney function are still controversial, principally due to the lack of isoform-specific inhibitors of NOS. OBJECTIVE: To investigate the relative roles of each isoform of NOS in regulation of sodium and volume homeostasis. DESIGN: We studied the effects of long-term modifications of sodium diet and blood pressure on expression of NOS mRNA in the renal cortex, where the three isoforms of NOS are present. METHODS: We used quantitative reverse-transcription-polymerase chain reaction assays specific to each isoform of NOS to determine amounts of their respective mRNA in control rats, deoxycorticosterone acetate (DOCA)-salt hypertensive rats, rats fed a high-salt diet, and furosemide-treated rats fed a low-sodium diet. Nicotinamide adenine nucleotide phosphate H (NADPH) diaphorase staining was performed on DOCA-salt and control rat kidneys. RESULTS: Levels of NOS I mRNA in DOCA-salt rats were decreased by treatment, those in low-salt-diet rats remained unaffected and those in high-salt diet rats tended to be intermediate between those of the other rat groups. Expression of NOS III mRNA was not significantly modified by either treatment Levels of NOS II mRNA in DOCA-salt rats were increased, those in high-salt-diet rats remained unaffected, and those in low-salt-diet were decreased by treatment, but these levels are more than 100-fold lower than those observed for the other isoforms of NOS. NADPH diaphorase staining in macula densa of DOCA-salt rats was markedly decreased compared with that in macula densa of control rats but staining in renal inflammatory and fibrous lesions became detectable, and staining in the vessels did not differ from that for control rats. CONCLUSIONS: Our results show that intake of sodium and extracellular fluid volume regulate levels of mRNA of the three NOS isoforms in the renal cortex differently, suggesting that each of them plays a specific role.
Assuntos
Pressão Sanguínea/fisiologia , Isoenzimas/genética , Rim/enzimologia , Óxido Nítrico Sintase/genética , RNA Mensageiro/metabolismo , Sódio/farmacologia , Animais , Desoxicorticosterona/farmacologia , Dieta Hipossódica , Histocitoquímica , Hipertensão/induzido quimicamente , Hipertensão/enzimologia , Rim/efeitos dos fármacos , Córtex Renal/enzimologia , Masculino , Óxido Nítrico Sintase Tipo I , Óxido Nítrico Sintase Tipo II , Óxido Nítrico Sintase Tipo III , Reação em Cadeia da Polimerase , Ratos , Ratos WistarRESUMO
1. This study was designed to evaluate the effects of aminoguanidine, a selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), on the reactivity and intracellular calcium ([Ca(2+)](i)) mobilization induced by noradrenaline in the perfused tail artery from aged WAG/Rij rats. Global mean internal diameter was 350+/-15 microns and wall thickness 161+/-3 microns. The influence of the endothelium on these responses was also analysed. The intracellular dye fura-2 for [Ca(2+)](i) measurements was used. 2. Noradrenaline-induced vasoconstriction decreased progressively from 3 to 20 and 30 months. Removal of the endothelium attenuated vasoconstriction in 20 and 30 month-old rats (P<0.05) but not in young rats. 3. Chronic administration of aminoguanidine (50 mg kg(-1) day(-1), p.o.) to WAG/Rij rats from 20 to 30 months enhanced (P<0. 01) the [Ca(2+)](i)-sensitivity of noradrenaline-induced vasoconstriction. 4. Aminoguanidine (300 microM) in vitro significantly shifted the concentration-vasoconstriction curve to noradrenaline to the left (P<0.01) in denuded vessels from both 20 and 30 month-old rats. The acute inhibitory effect of aminoguanidine was also observed after chronic aminoguanidine treatment. Aminoguanidine failed to modify vasoconstriction in the presence of the endothelium. 5. Acute aminoguanidine (300 microM) treatment did not modify vasoconstriction induced by noradrenaline in young rats. 6. Quantification of iNOS mRNA expression in tail arteries from 3 and 20 month-old WAG/Rij rats showed that expression was enhanced (x2.1, P<0.01) with age. 7. These results suggest that an inflammatory process develops in the media of the rat tail artery with age and that the subsequent increase in non-endothelial iNOS activity attenuates noradrenaline-induced vasoconstriction.
Assuntos
Endotélio Vascular/efeitos dos fármacos , Guanidinas/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Cauda/irrigação sanguínea , Vasoconstrição/efeitos dos fármacos , Fatores Etários , Animais , Artérias/efeitos dos fármacos , Artérias/fisiologia , Cálcio/metabolismo , Relação Dose-Resposta a Droga , Endotélio Vascular/fisiologia , Inibidores Enzimáticos/farmacologia , Masculino , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Norepinefrina/farmacologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Cauda/efeitos dos fármacos , Vasoconstrição/fisiologia , Vasoconstritores/farmacologiaRESUMO
Nitric oxide is synthesized by three isoenzymes widely distributed in the organism. The three genes encoding these enzymes show structural homology confirming that they are members of a protein family. Isoforms I (neuronal) and III (endothelial) are constitutive but their expression is transcriptionnaly regulated by various factors. NOS I promoter has not been studied yet, but alternative splicing around exons 9 and 10 has been described. SP1 binding on NOS III promoter is critical for its constitutive expression. NOS II isoform is inducible in a large variety of cells and seems also to be present constitutively in some tissues such as kidney. Functional studies of NOS II promoter reveal two important regions for lipopolysaccharides (- 85 à - 75) and interferon gamma (- 900 à - 975) induction. NOS III polymorphic markers allowed genetic studies which indicate that NOS III gene is not associated with human essential hypertension.
Assuntos
Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase/metabolismo , Animais , Clonagem Molecular , DNA Complementar , Regulação Enzimológica da Expressão Gênica , Humanos , Hipertensão/genética , Camundongos , Óxido Nítrico Sintase/classificação , RNA Mensageiro/genética , RatosRESUMO
The endothelial isoform of nitric oxide synthase (eNOS) ensures enzymatic production of nitric oxide (NO) not only in endothelial cells but also in other cell types, such as neurons, platelets, and some epithelial cells. Its physiological role has been well defined in some of these cells, such as relaxation of vascular smooth muscle cells, or long-term potentiation in neurons, owing to knockout experiments. Although constitutively expressed in endothelial cells, eNOS mRNA has been shown to be modulated by several physical, biochemical, and hormonal factors, acting at the transcriptional or post-transcriptional levels. Several functional regulatory elements have been mapped in the eNOS promoter, active both in endothelial and non-endothelial cells, and we present elements demonstrating that these elements are not sufficient to explain the high level of eNOS expression specific to endothelial cells.
Assuntos
Endotélio Vascular/fisiologia , Regulação Enzimológica da Expressão Gênica , Óxido Nítrico Sintase/genética , Animais , Plaquetas/enzimologia , Endotélio Vascular/enzimologia , Humanos , Músculo Liso Vascular/fisiologia , Neurônios/enzimologia , Neurônios/fisiologia , Óxido Nítrico Sintase Tipo III , VasodilataçãoRESUMO
Angiotensin I converting enzyme (ACE), also called dipeptidyl-carboxypeptidase I (DCP I), is a zinc metallopeptidase widely distributed on the surface of endothelial and epithelial cells. Its role in the vasoactive peptide, the metabolism of the two active peptides, angiotensin and bradykinin, and the beneficial effects of its inhibition in cardiovascular diseases, have raised considerable interest in this enzyme. The potential implications of ACE gene polymorphism, which affects the expression of the gene in cardiovascular diseases, has been widely investigated. This review summarizes the results of these studies.
Assuntos
Hipertrofia Ventricular Esquerda/genética , Infarto do Miocárdio/genética , Peptidil Dipeptidase A/genética , Polimorfismo Genético , Regulação Enzimológica da Expressão Gênica/fisiologia , Genótipo , Humanos , FenótipoRESUMO
Mammalian rRNA genes are preceded by a terminator element that is recognized by the transcription termination factor TTF-I. In exploring the functional significance of the promoter-proximal terminator, we found that TTF-I associates with the p300/CBP-associated factor PCAF, suggesting that TTF-I may target histone acetyltransferase to the rDNA promoter. We demonstrate that PCAF acetylates TAF(I)68, the second largest subunit of the TATA box-binding protein (TBP)-containing factor TIF-IB/SL1, and acetylation enhances binding of TAF(I)68 to the rDNA promoter. Moreover, PCAF stimulates RNA polymerase I (Pol I) transcription in a reconstituted in vitro system. Consistent with acetylation of TIF-IB/SL1 being required for rDNA transcription, the NAD(+)-dependent histone deacetylase mSir2a deacetylates TAF(I)68 and represses Pol I transcription. The results demonstrate that acetylation of the basal Pol I transcription machinery has functional consequences and suggest that reversible acetylation of TIF-IB/SL1 may be an effective means to regulate rDNA transcription in response to external signals.
Assuntos
Acetiltransferases/metabolismo , Proteínas de Ligação a DNA/metabolismo , Proteínas Pol1 do Complexo de Iniciação de Transcrição , RNA Polimerase I/biossíntese , Proteínas de Saccharomyces cerevisiae , Proteínas Reguladoras de Informação Silenciosa de Saccharomyces cerevisiae , Fatores de Transcrição/metabolismo , Acetilação , Acetiltransferases/antagonistas & inibidores , Animais , DNA Ribossômico , Regulação Enzimológica da Expressão Gênica , Inativação Gênica , Histona Acetiltransferases , Histona Desacetilases/metabolismo , Ácidos Hidroxâmicos/farmacologia , Camundongos , Ligação Proteica , Subunidades Proteicas , RNA Polimerase I/genética , Proteínas Recombinantes/metabolismo , Sirtuína 2 , Sirtuínas , Proteína de Ligação a TATA-Box , Regiões Terminadoras Genéticas , Transativadores/metabolismo , Transcrição GênicaRESUMO
The endothelial nitric-oxide synthase gene is constitutively expressed in endothelial cells. Several transcriptionally active regulatory elements have been identified in the proximal promoter, including a GATA-2 and an Sp-1 binding site. Because they cannot account for the constitutive expression of endothelial nitric-oxide synthase gene in a restricted number of cells, we have searched for other cell-specific regulatory elements. By DNase I hypersensitivity mapping and deletion studies we have identified a 269-base pair activator element located 4.9 kilobases upstream from the transcription start site that acts as an enhancer. DNase I footprinting and linker-scanning experiments showed that several regions within the 269-base pair enhancer are important for transcription factor binding and for full enhancer activity. The endothelial specificity of this activation seems partly due to interaction between this enhancer in its native configuration and the promoter in endothelial cells. EMSA experiments suggested the implication of MZF-like, AP-2, Sp-1-related, and Ets-related factors. Among Ets factors, Erg was the only one able to bind to cognate sites in the enhancer, as found by EMSA and supershift experiments, and to activate the transcriptional activity of the enhancer in cotransfection experiments. Therefore, multiple protein complexes involving Erg, other Ets-related factors, AP-2, Sp-1-related factor, and MZF-like factors are important for the function of this enhancer in endothelial cells.
Assuntos
Elementos Facilitadores Genéticos , Óxido Nítrico Sintase/genética , Regiões Promotoras Genéticas , Sequência de Bases , Sítios de Ligação , Células Cultivadas , Desoxirribonuclease I/farmacologia , Humanos , Dados de Sequência Molecular , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo III , Nucleoproteínas/metabolismo , Fatores de Transcrição/metabolismoRESUMO
Endothelium-derived relaxing factor (EDRF)/nitric oxide (NO) is synthesized from L-Arginine by the endothelial, constitutive, NO synthase. No facilitate genetic studies, we have cloned the human endothelial NO synthase gene and determined its structure. The gene is composed of 26 exons, ranging from 68 to 579 bp and spans 22 kb. We determined the transcription start point using human lung mRNA. No TATA-box was found at the expected distance from the transcription start point and several consensus sequences for transcription factors, including a shear-stress responsive element were identified in the 5'-flanking region. A highly polymorphic (CA) repeat within intron 13 was studied, allowing the precise genetic mapping of the gene to chromosome 7, within a 4 cM interval delimited by genethon markers AFM199Zd4 and AFM074Xg5.
Assuntos
Aminoácido Oxirredutases/genética , Cromossomos Humanos Par 7 , Endotélio/enzimologia , Polimorfismo Genético , Alelos , Aminoácido Oxirredutases/biossíntese , Sequência de Bases , Mapeamento Cromossômico , Clonagem Molecular , Cosmídeos , Primers do DNA , DNA Satélite/genética , Éxons , Feminino , Biblioteca Genômica , Humanos , Íntrons , Pulmão/enzimologia , Dados de Sequência Molecular , Óxido Nítrico Sintase , Placenta/enzimologia , Reação em Cadeia da Polimerase , Gravidez , Regiões Promotoras Genéticas , RNA Mensageiro/metabolismo , Proteínas Recombinantes/biossíntese , Sequências Repetitivas de Ácido Nucleico , Transcrição GênicaRESUMO
Polymerase chain amplification experiments indicate that the germinal specific promoter of the angiotensin I-converting enzyme (ACE) is completely extinguished in somatic tissues. Despite this very strict specificity of expression, the germinal ACE promoter is active in transient transfection experiments in two somatic cell lines and one cell line of germinal origin. The analysis of the promoter shows the existence two regulatory elements within the first 350 bp: a proximal positive element and a distal negative element.
Assuntos
Dipeptidil Peptidases e Tripeptidil Peptidases/genética , Ovário/enzimologia , Peptidil Dipeptidase A/genética , Regiões Promotoras Genéticas , Testículo/enzimologia , Animais , Sequência de Bases , Catepsina C , Linhagem Celular , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Clonagem Molecular , Colforsina/farmacologia , AMP Cíclico/metabolismo , Éxons , Feminino , Humanos , Íntrons , Luciferases/genética , Luciferases/metabolismo , Masculino , Camundongos , Dados de Sequência Molecular , Oligodesoxirribonucleotídeos , Especificidade de Órgãos , Plasmídeos , Reação em Cadeia da Polimerase , RNA/genética , RNA/isolamento & purificação , Sequências Reguladoras de Ácido NucleicoRESUMO
BACKGROUND: The basal release of nitric oxide by the endothelium plays an important role in regulating blood flow and pressure and mediates most of the endothelium-dependent vasodilation. Impairment of nitric oxide production by specific inhibitors increases blood pressure in humans, and several reports suggest that hypertensive subjects have a blunted endothelium-dependent vasodilatation that might be secondary to decreased nitric oxide production from the vessel wall. METHODS AND RESULTS: To determine whether the endothelial nitric oxide synthase gene is involved in human essential hypertension, we identified informative biallelic and multiallelic markers of this locus and performed case-control and linkage studies in hypertensive subjects and normotensive control subjects. We used the affected sib pair method to test for potential linkage in 145 hypertensive pedigrees (269 sib pairs, 346 subjects) with a highly polymorphic marker of the nitric oxide synthase gene (polymorphism information content of 92%). There was no evidence for linkage among affected siblings. The 95% upper confidence limit of this value suggests that at most 1% of alleles in excess of expected are shared. We also identified two informative biallelic markers of this gene to perform a case-control study on white hypertensive and normotensive subjects. Similar genotype distributions between the two groups were noted for both markers. Estimated haplotype frequencies by maximum likelihood methods combining the two biallelic markers were also similar in both groups. CONCLUSIONS: These findings do not suggest that common molecular variants of the endothelial nitric oxide synthase gene are involved in essential hypertension.
Assuntos
Aminoácido Oxirredutases/genética , Hipertensão/genética , Adulto , Sequência de Bases , Sondas de DNA , Endotélio Vascular/enzimologia , Feminino , Frequência do Gene , Ligação Genética , Humanos , Hipertensão/enzimologia , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Óxido Nítrico Sintase , Linhagem , Reação em Cadeia da Polimerase , Polimorfismo GenéticoRESUMO
Physiological adaptation of normal blood vessels to acute or chronic changes in blood flow is endothelium dependent. In vitro studies have shown that, among other genes, NO synthase (NOS) 3 mRNA and protein expression is enhanced by acute elevation of shear stress in endothelial cells. We have investigated the effect of chronic high blood flow on NOS3 mRNA and protein expression in rat aorta. NOS3 mRNA levels were measured by quantitative polymerase chain reaction (PCR) in the aortas of 12 rats with arteriovenous fistulas and 9 sham-operated control rats. The PCR assay indicated that NOS3 mRNA levels were significantly enhanced (twofold) during high blood flow. Western blots showed that immunoreactive NOS3 levels were also increased to a similar extent. Furthermore, the Ca(2+)-dependent NOS activity, measured by the L-arginine to L-citrulline conversion assay, and the cGMP content were also significantly increased in the proximal aortic wall submitted to the arteriovenous shunt. These results indicate that NOS3 mRNA and protein expression is enhanced in vivo during chronic high blood flow.
Assuntos
Aorta/enzimologia , Endotélio Vascular/enzimologia , Óxido Nítrico Sintase/biossíntese , RNA Mensageiro/biossíntese , Animais , Aorta/patologia , Sequência de Bases , Endotélio Vascular/patologia , Masculino , Ratos , Ratos Wistar , Estresse MecânicoRESUMO
The influence of age on endothelial functional markers was investigated in rats. Angiotensin I converting enzyme (ACE) activity and nitric oxide synthase (NOS) mRNA expressions were examined in the lung and aorta of 10-, 20-, and 30-mo-old normotensive rats. These data were extended by the measurement of circulating endothelial cells. ACE activity was significantly decreased in plasma (P < 0.01) and lungs (P < 0.01) at 30 mo, whereas it was significantly increased in the aorta (P < 0.001) at this age. Conversely, ACE mRNA levels decreased with age in the lung (P < 0.05). The level of constitutive endothelial NOS (eNOS) mRNA was significantly reduced in the aorta of 30-mo-old rats (P < 0.05), but no changes were observed in the lungs. The level of inducible NOS (iNOS) mRNA in the aorta was significantly decreased in 20- and 30-mo-old rats (P < 0.01), whereas it was significantly increased in the lung at 30 mo (P < 0.01). Interestingly, eNOS was expressed approximately 30 times more (P < 0.001) in the aorta than iNOS, whereas in the lung it was only slightly higher than iNOS (35%; P < 0.001). Neuronal NOS mRNA expression was not modified with aging. In the aorta, guanosine 3',5'-cyclic monophosphate concentration followed NOS expressions and showed a significant decrease at 30 mo (P < 0.001). An increase in the number of circulating endothelial cells was observed in the oldest rats, possibly reflecting an increase in endothelial cell turnover with aging. The present results demonstrate that aging modifies the expression of endothelial markers implicated in the regulation of vasomotor tone. This age-dependent impairment of endothelial functions could contribute to the increased risk of pathological processes within the arterial wall associated with aging.
Assuntos
Envelhecimento/metabolismo , Aorta/metabolismo , Pulmão/metabolismo , Óxido Nítrico Sintase/genética , Peptidil Dipeptidase A/genética , RNA Mensageiro/metabolismo , Envelhecimento/sangue , Animais , Biomarcadores/sangue , Masculino , Reação em Cadeia da Polimerase , RNA Mensageiro/sangue , RatosRESUMO
Pregnancy-induced hypertension may be regarded as a manifestation of endothelial-cell dysfunction. The role of the eNOS gene in the development of a familial pregnancy-induced hypertension was evaluated by analysis of linkage among affected sisters and in multiplex families (n = 50). Markers from a 4-cM region encoding the eNOS gene showed distortion from the expected allele sharing among affected sisters (P = .001-.05), and the statistic obtained from the multilocus application of the affected-pedigree-member method also showed distortion (T[f(P)=sqrt(P)] = 3.53; P < .001). A LOD score of 3.36 was obtained for D7S505 when a best-fitting model derived from genetic epidemiological data was used, and LOD scores of 2.54-4.03 were obtained when various other genetic models were used. Estimates of recombination rate, rather than maximum LOD-score values, were affected by changes in the genetic parameters. The transmission-disequilibrium test, a model-free estimate of linkage, showed strongest association and linkage with a microsatellite within intron 13 of the eNOS gene (P = .005). These results support the localization of a familial pregnancy-induced hypertension-susceptibility locus in the region of chromosome 7q36 encoding the eNOS gene.